Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Lumināt Secures $2.3M Series A Funding and Perpetual Licensing Agreement from City of HopeBy: Luminat, LLC “We are pleased to support Lumināt in its next phase of growth,” said City of Hope Chief Financial Officer Ric Magnuson. “Like City of Hope, Lumināt is committed to enhancing patient care through innovative technology solutions, and we believe this partnership will deliver essential products to patients, family members and their medical providers.” The financing follows Lumināt’s initial seed investment of $750,000. Lumināt’s leadership team, consisting of experienced healthcare executives with demonstrated success in bringing new products to market, will leverage this round of funding to enhance and expand its product offerings and reposition itself in the industry. “City of Hope is an ideal partner as we enter this next stage of development,” The Series A funding for Lumināt is the first of its kind from City of Hope. “City of Hope is confident in the success of the investment, the co-development and the licensing partnership, as well as the qualified team at Lumināt,” said George Megaw, director of technology licensing at City of Hope. “Together, we will accelerate City of Hope’s efforts to propagate the SupportScreen technology to more patients.” ### About Lumināt Lumināt (pronounced loo-‐mi-‐ About City of Hope City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, Calif., just northeast of Los Angeles, with community clinics in southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. Contacts Kristin Austrum VP, Product & Marketing Lumināt 612-382-9107 kaustrum@luminat.com Tami Dennis Associate VP, Communications City of Hope 626-218-6279 End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|